Abstract
The structure of a protein is closely linked to its function. Many proteins undergo conformational changes while working in living cells. Consequently, proteins in various structural states coexist in the native cellular environment. Understanding the structural heterogeneity of proteins in living cells is essential for understanding the kinetics of protein reactions. Single-molecule Förster resonance energy transfer (smFRET) is a powerful tool for probing the structure of biomolecules at the single-molecule level. Confocal smFRET measurements, which obtain the smFRET distribution of freely diffusing single molecules, have been successfully applied to cytosolic proteins in living cells. Previous studies on CRAF, a member of the RAF kinase family, revealed the coexistence of at least three conformational states and critical interactions with 14-3-3 proteins. In this study, we applied the method to, in addition to wild-type (WT) CRAF, to mutants at important sites, and to co-expression with other proteins related to RAF activation. The detailed analyses comparing those results suggest the presence of a fourth minor conformational state of CRAF in addition to the previously identified three major states. This fourth state may be related to RAF dimers. Supported by a newly introduced burst intensity analysis, we also found that the three major components can be classified into two groups: two interconvertible components and one independent component. Furthermore, in-cell smFRET measurement of wild-type BRAF, another RAF family member, revealed that its structural distribution consists primarily of a single species, which seemingly corresponds to the lowest FRET component among the three structural states of WT-CRAF. This finding suggests that BRAF has a fundamentally different structural and regulatory mechanism than CRAF.
Affiliated Institutions
Related Publications
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Tumours with mutant BRAF are dependent on the RAF–MEK–ERK signalling pathway for their growth. We found that ATP-competitive RAF inhibitors inhibit ERK signalling in cells with ...
The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
Tumors with mutant BRAF and some with mutant RAS are dependent upon ERK signaling for proliferation, and their growth is suppressed by MAPK/ERK kinase (MEK) inhibitors. In contr...
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have broad therapeutic...
Probing the interaction between two single molecules: fluorescence resonance energy transfer between a single donor and a single acceptor.
We extend the sensitivity of fluorescence resonance energy transfer (FRET) to the single molecule level by measuring energy transfer between a single donor fluorophore and a sin...
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
BRAF is an attractive target for melanoma drug development. However, resistance to BRAF inhibitors is a significant clinical challenge. We describe a model of resistance to BRAF...
Publication Info
- Year
- 2025
- Type
- article
- Volume
- 12
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.3389/fmolb.2025.1718018